183180
Tetrathiafulvalene
97%
Synonym(s):
Δ2,2′-Bi-1,3-dithiole, TTF
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C6H4S4
CAS Number:
Molecular Weight:
204.36
Beilstein:
1617956
EC Number:
MDL number:
UNSPSC Code:
12352103
PubChem Substance ID:
NACRES:
NA.23
Recommended Products
Assay
97%
form
solid
mp
116-119 °C (lit.)
SMILES string
S1C=CS\C1=C2/SC=CS2
InChI
1S/C6H4S4/c1-2-8-5(7-1)6-9-3-4-10-6/h1-4H
InChI key
FHCPAXDKURNIOZ-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
Tetrathiafulvalene (TTF) is an electron-donor which consists of oligomers, dendrimers and polymers which can be used in the formation of redox macromolecules.
Application
TTF may be linked with lithium chloride (LiCl) to form a precipitated layer on the lithium oxide (Li2O2) for the fabrication of high performance Li-O2 batteries. Bio-sourced carbon nanodots can be surface modified by TTF which can be potentially used for electrochemical applications.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Exploring Tetrathiafulvalene-Carbon Nanodot Conjugates in Charge Transfer Reactions.
Ferrer-Ruiz A, et al.
Angewandte Chemie (International Edition in English), 57(4), 1001-1005 (2018)
Chemical Society Reviews, 23, 41-41 (1994)
Tetrahedron Letters, 35, 8675-8675 (1994)
Surface-nhanced near-infrared fourier transform Raman scattering of tetrathiafulvalene adsorbed on silver powder
Nie, S., & Yu, N. T.
Journal of Raman Spectroscopy, 22(9), 489-495 (1991)
Laurence Albiges et al.
European journal of cancer (Oxford, England : 1990), 51(17), 2580-2586 (2015-09-09)
Monoclonal antibodies that target the programmed death-1 (PD-1)/programmed death-ligand 1(PD-L1) pathway have shown antitumour activity in metastatic renal cell carcinoma (mRCC) and are currently being developed in first-line (in combination) and in previously treated patients. The efficacy targeted therapy (TT)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service